Hiberix Kit
Product Images NDC 58160-818

5 FDA label images from Glaxosmithkline Biologicals Sa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Hiberix (NDC 58160-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Biologicals Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Hiberix Spl Graphic 01)

Figure 1 (Hiberix Spl Graphic 01)
An instructional illustration showing a syringe drawing 0.6 mL of saline diluent from a vial. The arrows indicate the direction of fluid movement from the vial into the syringe.*
FDA Label Image

Figure 2 (Hiberix Spl Graphic 02)

Figure 2 (Hiberix Spl Graphic 02)
An instructional illustration showing the preparation of the Hiberix vaccine kit. It depicts a syringe being inserted into a vial labeled 'Lyophilized Vaccine,' with an arrow indicating the direction to pull or mix the contents, demonstrating reconstitution steps of the Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) kit by GlaxoSmithKline Biologicals SA.*
FDA Label Image

Figure 3 (Hiberix Spl Graphic 03)

FDA Label Image

Figure 4 (Hiberix Spl Graphic 04)

Figure 4 (Hiberix Spl Graphic 04)
An instructional diagram showing the reconstitution of the Hiberix vaccine. It depicts a vial connected to a syringe with an arrow indicating the transfer of 0.5 mL of reconstituted vaccine to the syringe for administration, illustrating the preparation process for Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate).*
FDA Label Image

Vial Carton (Hiberix Spl Graphic 05)

Vial Carton (Hiberix Spl Graphic 05)
Label of Hiberix Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) kit by GlaxoSmithKline Biologicals SA. The label states the product is for use from 6 weeks through 4 years of age and contains 10 vials of lyophilized vaccine and 10 vials of sterile saline diluent for reconstitution. The label includes the NDC 58160-818-11 and a pink sidebar indicating it's a Hib vaccine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.